Carcinoma, Non-Small-Cell Lung
Showing NaN - NaN of 53
Triple-Negative Breast Tumors, NSCLC, Head and Neck Carcinoma, Squamous Cell Trial in Worldwide (TAK-659, Nivolumab)
Terminated
- Triple-Negative Breast Neoplasms
- +3 more
-
La Jolla, California
- +21 more
Mar 18, 2020
NSCLC Trial in United States (REGN4659, Cemiplimab)
Terminated
- Carcinoma, Non-Small-Cell Lung
-
Chicago, Illinois
- +5 more
Mar 11, 2020
NSCLC Trial in Worldwide (Atezolizumab, Daratumumab)
Completed
- Carcinoma, Non-Small-Cell Lung
-
Loma Linda, California
- +46 more
Nov 5, 2019
NSCLC, NSCLC Trial in Spain, United States (CC-223, erlotinib, CC-223, oral azacitidine)
Completed
- Carcinoma, Non-Small-Cell Lung
- Non-Small Cell Lung Cancer
- CC-223, erlotinib
- CC-223, oral azacitidine
-
Los Angeles, California
- +8 more
Nov 7, 2019
NSCLC Trial in Worldwide (Emibetuzumab, Erlotinib)
Completed
- Carcinoma, Non-Small-Cell Lung
-
Birmingham, Alabama
- +58 more
Sep 6, 2019
NSCLC Trial in Worldwide (IMC-1121B (ramucirumab), Pemetrexed, Carboplatin (AUC 6))
Completed
- Carcinoma, Non-Small-Cell Lung
- IMC-1121B (ramucirumab)
- +5 more
-
Scottsdale, Arizona
- +52 more
Aug 28, 2019
NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)
Terminated
- Carcinoma, Non-Small-Cell Lung
- +7 more
-
Birmingham, Alabama
- +10 more
Jul 17, 2019
NSCLC Trial in United States (nab-Paclitaxel, Carboplatin)
Completed
- Carcinoma, Non-Small-Cell Lung
-
Boynton Beach, Florida
- +7 more
Dec 4, 2018
NSCLC Trial in United States (JNJ-64041757 (Cohort 1A and 1B), JNJ-64041757 (Cohort 2A and 2B))
Terminated
- Carcinoma, Non-Small-Cell Lung
- JNJ-64041757 (Cohort 1A and 1B)
- JNJ-64041757 (Cohort 2A and 2B)
-
Duarte, California
- +8 more
Nov 21, 2018
NSCLC Trial in United States (SNS-595 Injection)
Completed
- Carcinoma, Non-Small-Cell Lung
- SNS-595 Injection
-
Scottsdale, Arizona
- +3 more
Dec 8, 2017
NSCLC, Lung Tumors Trial in Worldwide (HKI-272)
Completed
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
-
Los Angeles, California
- +18 more
Apr 6, 2018
Anemia, NSCLC, Carcinoma, Small-Cell Lung Trial in United States (Sotatercept 15 mg, Sotatercept 30 mg)
Terminated
- Anemia
- +5 more
- Sotatercept 15 mg
- Sotatercept 30 mg
-
Phoenix, Arizona
- +40 more
Nov 14, 2017
Non-Small-Cell Lung Cancer Stage IIIB, Non-Small-Cell Lung Cancer Stage IV, Non-Small-Cell Lung Cancer Metastatic Trial in
Completed
- Non-Small-Cell Lung Cancer Stage IIIB
- +6 more
- bavituximab
- +2 more
-
Huntsville, Alabama
- +160 more
Apr 19, 2017
NSCLC Trial in Worldwide (PF-02341066)
Completed
- Carcinoma, Non-Small-Cell Lung
-
Birmingham, Alabama
- +278 more
Nov 17, 2016
NSCLC Trial in Worldwide (PF-02341066, Pemetrexed, Docetaxel)
Completed
- Carcinoma, Non-Small-Cell Lung
- PF-02341066
- +2 more
-
Little Rock, Arkansas
- +263 more
Oct 31, 2016
NSCLC Trial in United States (afatinib, loperamide)
Completed
- Carcinoma, Non-Small-Cell Lung
-
Santa Rosa, California
- +11 more
Sep 8, 2016
NSCLC Trial in Worldwide (MM-121, Erlotinib)
Completed
- Carcinoma, Non-Small-Cell Lung
-
Birmingham, Alabama
- +37 more
Jul 12, 2016
NSCLC Trial in Netherlands, United States (Cetuximab, BIBW 2992)
NSCLC Trial in United States (TRAIL-R1 mAb (TRM-1;HGS-ETR1))
Completed
- Carcinoma, Non-Small-Cell Lung
- TRAIL-R1 mAb (TRM-1;HGS-ETR1)
-
Denver, Colorado
- +4 more
Aug 1, 2013
NSCLC, Lung Tumors Trial in United States (Investigational drug)
Completed
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Investigational drug
-
Berkeley, California
- +11 more
Feb 14, 2012